Pharmacodynamic, Safety, And Efficacy Results Of A Phase I/Ii Trial Of Intratumoral Int230-6 Alone (It-01) Or In Combination With Pembrolizumab (Pem) (Keynote A10) In Patients With Advanced Solid Tumors.

Jacob Stephen Thomas,Anthony B. El-Khoueiry,Ian B. Walters,Nilofer Saba Azad,Lewis H. Bender,Diana L. Hanna,Giles Francis Whalen,Anthony J. Olszanski,Lillian L. Siu

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 1|浏览47

暂无评分

摘要

3016Background: INT230-6 is comprised of cisplatin (CIS), vinblastine (VIN) and an amphiphilic penetration enhancer which facilitates dispersion throughout tumors and diffusion into cancer cells wh...

查看译文

关键词

pembrolizumab,advanced solid tumors,keynote a10

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要